Study of the Combination of DKN-01 and Nivolumab in Previously Treated Patients With Advanced Biliary Tract Cancer (BTC)
Clinical trial NCT04057365 · TERMINATED
Trial details
- NCT number
- NCT04057365
- Sponsor
- Massachusetts General Hospital
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-07
- Primary completion
- 2022-09-25
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.